Three add $50M FDA IDIQ Contracts for CBER Biologics Effectiveness and Safety (BEST) Initiative #3: Data Sources for Surveillance of Biologics (BEST 3)

Notice ID: FDA-SOL-1224068

The FDA has awarded three contracts for CBER Biologics Effectiveness and Safety (BEST) Initiative #3: Data Sources for Surveillance of Biologics (BEST 3), with a $50M IDIQ ceiling and $10,000 minimum guarantee for each contract.

Awardees:

1. The Lewin Group, Inc., Contract: 75F40120D00026, Award date: 9/30/20.
2. IQVIA Government Solutions, Inc, Contract: 75F40120D00027, Award date: 9/29/20.
3. AETNA INC./Healthagen LLC, Contract: F40120D00028, Award date: 9/29/20.

Read more here.